German private equity firm Aurelius has agreed to buy Reckitt Benckiser 's ( OTCPK:RBGLY ) Scholl shoe business. The company is expecting the brand to expand internationally and maintain growth
FRANKFURT, July 21 (Reuters) - German private equity firm Aurelius said on Monday it is buying Reckitt Benckiser 's Scholl shoe business in its efforts to expand internationally, betting on the brand's growth potential.
July 21 (Reuters) - Aurelius AG : * Says to acquire Scholl's footwear division from Reckitt Benckiser Group plc * Says completion is scheduled for Q3 2014 * Source text for Eikon * Further company coverage
reverses the overdose of prescription and illicit opioids. An intranasal delivery system is under development. Reckitt Benckiser has teamed up with AntiOp to develop a nasal delivery product as well. Post your comment!
Reckitt Benckiser today announced the acquisition of the global rights to the K-Y brand from Johnson & Johnson for an undisclosed amount. The
Reckitt Benckiser ’s third-quarter sales update showcased modest top-line underlying growth (3% in total, 5% excluding the pharmaceuticals segment
A strong cold and flu season propped up Reckitt Benckiser 's RB . first-half results (underlying sales up 6% year over year) . However, adjusted operating margins slipped 80 basis points
Despite the ills faced by consumers, Reckitt Benckiser RB . actually benefited from the strong cold and flu season, as evidenced in its first-quarter trading update. Adjusting for acquisitions
In line with the plan laid out a year ago, Reckitt Benckiser ’s RB . focus on expanding in health and hygiene (particularly in emerging regions) is taking shape, supporting our narrow economic
launching a $42 per share tender offer (a total price tag of $1.4 billion) for Schiff Nutrition International, Reckitt Benckiser RB . announced the two firms signed a merger agreement, and as such, we now believe a deal is imminent. This follows